Breast Implants May be Associated With Rare Lymphoma, FDA Says

There are currently no known risk factors, and further investigation is warranted.

“Additional research is critical to identify patients at risk of developing this disease, characterize the early signs and symptoms, and determine best practices for treatment,” the American Society of Plastic Surgeons and the Plastic Surgery Foundation said in a release, noting that common symptoms include spontaneous seroma (collection of fluid under the skin) or effusion after about a year of implantation.

The FDA urged consumers considering breast implants to talk to their health care provider about the risks and benefits of textured-surface versus smooth-surface implants. Further, they noted that individuals who already have breast implants do not need to drastically change their health care or follow-up routines. They should just continue to monitor the implants as per their doctors’ orders and, if their implants are silicone-filled, have frequent MRIs, as instructed by their providers.

Leave a Reply

Your email address will not be published. Required fields are marked *